DUBLIN, Ireland, January 28, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/kdgxkz/opportunities_in) has announced the addition of the "Human Embryonic Stem Cell (hESC) Products Industry - Opportunities and Forecasts to 2017" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including:
Embryonic stem cells are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days post-fertilization. They are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body. Human embryonic stem cells (hESCs) were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin.
Key Topics Covered:
I. STRATEGIC OVERVIEW
II. ACCESS & AVAILABILITY OF hESC LINES
A. NIH Registry Approved hESC Lines
B. Sources of Additional Published hESC Lines
C. Sources of Additional Unpublished hESC Lines
III. END-USER APPLICATIONS OF hESCs
A. Basic Research
B. Cellular Therapies
C. Tissue Engineering
D. Toxicology Testing
IV. PATENT ENVIRONMENT
A. Landmark hESC Patents: WARF Composition of Matter Patents
B. Global Stem Cell Patent Landscape
C. U.S. Patents of Importance
D. Worldwide Patents of Importance
E. Summary of the hESC Intellectual Property Landscape
V. MARKET TREND ANALYSIS - FUTURE GROWTH PROJECTIONS
A. Scientific Publication Analysis
B. Grant Analysis
C. Patent Analysis
VI. MARKET SIZE
A. Definitions
B. Experimental Approach
C. Annual Market Size - Human Embryonic Stem Cell Products
VII. MARKET CHARACTERIZATION
A. Key Research Applications
B. Geographical Breakdown (Country-by-Country Breakdown)
VIII. hESC RESEARCH SUPPLY COMPETITORS
A. Cellartis AB
B. Vitrolife
C. Tataa Biocenter
D. Invitrogen
E. Stem Cell Technologies
F. BD Biosciences
G. Chemicon
H. R&D Systems
I. SA Biosciences
J. Thermo Scientific
K. Australian Stem Cell Centre
IX. SPECIALTY PHARMACEUTICAL COMPANIES DEVELOPING hESC THERAPIES
A. Geron
B. Novocell
C. Cell Cure Neurosciences Ltd
D. Cell Dynamics International
E. Advanced Cell Technology
X. TOXICOLOGY TESTING LEGISLATION
A. European Union Ban of Animal-Testing for Cosmetic Development (2013)
B. Responses to the European Ban on Animal Testing for Cosmetic Development
C. EU Legislation Regarding Animal-Based Testing for Drug Discovery
XI. STRATEGIC PRODUCT & TECHNOLOGY DEVELOPMENT
A. Product Categories
B. Product Ideas & Suggestions
XII. STRATEGIES FOR ACCESSING THE MARKETPLACE
A. Top Research Institutions Performing hESC Research
B. Events of Interest - hESC Conferences & Symposiums
XIII. SCIENTIST PANEL: DETAILED END-USER SURVEY
A. Survey Overview
B. Characterization of Market Survey Respondents
C. Survey Findings
D. Terms Used in Online Product Search
XIV. CONCLUSIONS
APPENDIX
Human Embryonic Stem Cell Research Centers & Contact Information
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/kdgxkz/opportunities_in
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article